Threshold Pharmaceuticals, Inc. Share Price Nasdaq
Equities
US8858072064
Biotechnology & Medical Research
Sales 2024 * | 12.7M 1.01B | Sales 2025 * | 1.37M 109M | Capitalization | 11.23M 896M |
---|---|---|---|---|---|
Net income 2024 * | -22M -1.76B | Net income 2025 * | -34M -2.71B | EV / Sales 2024 * | 0.88 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 8.21 x |
P/E ratio 2024 * |
-0.52
x | P/E ratio 2025 * |
-0.43
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.04% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Poma
CEO | Chief Executive Officer | 52 | 31/12/99 |
Jason Kim
PSD | President | 49 | 31/12/09 |
Kristen Quigley
COO | Chief Operating Officer | 53 | 31/12/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Poma
CEO | Chief Executive Officer | 52 | 31/12/99 |
Harold Selick
CHM | Chairman | 69 | 31/07/17 |
David Hoffmann
BRD | Director/Board Member | 79 | 31/07/17 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |